|
🐜
|
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
15 auth.
Luca Valenti,
Ahmad E. Al-Serri,
A. Daly,
E. Galmozzi,
R. Rametta,
P. Dongiovanni,
V. Nobili,
E. Mozzi,
G. Roviaro,
E. Vanni,
...
E. Bugianesi,
M. Maggioni,
A. Fracanzani,
S. Fargion,
C. Day
|
9 |
2010 |
9
🐜
|
|
🐜
|
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
28 auth.
P. Dongiovanni,
S. Petta,
C. Maglio,
A. Fracanzani,
R. Pipitone,
E. Mozzi,
B. Motta,
D. Kamińska,
R. Rametta,
S. Grimaudo,
S. Pelusi,
T. Montalcini,
A. Alisi,
M. Maggioni,
V. Kärjä,
...
J. Borén,
P. Käkelä,
V. Di Marco,
Chao Xing,
V. Nobili,
B. Dallapiccola,
A. Craxì,
J. Pihlajamäki,
S. Fargion,
L. Sjöström,
L. Carlsson,
S. Romeo,
Luca Valenti
|
8 |
2015 |
8
🐜
|
|
🐜
|
Statin use and non-alcoholic steatohepatitis in at risk individuals.
19 auth.
P. Dongiovanni,
S. Petta,
V. Mannisto,
R. Mancina,
R. Pipitone,
V. Karja,
M. Maggioni,
Pirjo Kakela,
O. Wiklund,
E. Mozzi,
...
S. Grimaudo,
D. Kamińska,
R. Rametta,
A. Craxì,
S. Fargion,
V. Nobili,
S. Romeo,
J. Pihlajamaki,
Luca Valenti
|
8 |
2015 |
8
🐜
|
|
🐜
|
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
21 auth.
P. Dongiovanni,
S. Stender,
A. Pietrelli,
R. Mancina,
A. Cespiati,
S. Petta,
S. Pelusi,
P. Pingitore,
S. Badiali,
M. Maggioni,
...
V. Mannisto,
S. Grimaudo,
R. Pipitone,
J. Pihlajamaki,
A. Craxì,
M. Taube,
L. Carlsson,
S. Fargion,
S. Romeo,
J. Kozlitina,
Luca Valenti
|
8 |
2017 |
8
🐜
|
|
🐜
|
Patatin‐Like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
12 auth.
L. Valenti,
M. Rumi,
E. Galmozzi,
A. Aghemo,
Benedetta del Menico,
S. De nicola,
...
P. Dongiovanni,
M. Maggioni,
A. Fracanzani,
R. Rametta,
M. Colombo,
S. Fargion
|
8 |
2011 |
8
🐜
|
|
🐜
|
Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis.
9 auth.
M. Ponzoni,
G. Arrigoni,
V. Gould,
B. Curto,
M. Maggioni,
Antonio Scapinello,
...
Salvatore Paolino,
Angelo Cassisa,
C. Patriarca
|
8 |
2000 |
8
🐜
|
|
🐜
|
Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial
15 auth.
S. Bruno,
P. Maisonneuve,
P. Castellana,
N. Rotmensz,
S. Rossi,
M. Maggioni,
M. Persico,
A. Colombo,
F. Monasterolo,
D. Casadei-Giunchi,
...
F. Desiderio,
T. Stroffolini,
V. Sacchini,
A. Decensi,
U. Veronesi
|
7 |
2005 |
7
🐜
|
|
🐜
|
Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis
9 auth.
L. N. Valenti,
R. Rametta,
P. Dongiovanni,
M. Maggioni,
A. Fracanzani,
M. Zappa,
...
E. Lattuada,
G. Roviaro,
S. Fargion
|
7 |
2007 |
7
🐜
|
|
🐜
|
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
17 auth.
P. Dongiovanni,
L. N. Valenti,
R. Rametta,
A. Daly,
V. Nobili,
E. Mozzi,
J. Leathart,
A. Pietrobattista,
A. Burt,
M. Maggioni,
...
A. Fracanzani,
E. Lattuada,
M. Zappa,
G. Roviaro,
G. Marchesini,
C. Day,
S. Fargion
|
7 |
2010 |
7
🐜
|
|
🐬
|
Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.
A. Nicolini,
L. Martinetti,
S. Crespi,
M. Maggioni,
A. Sangiovanni
|
7 |
2010 |
7
🐬
|
|
🐜
|
Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma
12 auth.
C. Augello,
Luca Caruso,
M. Maggioni,
M. Donadon,
M. Montorsi,
R. Santambrogio,
...
G. Torzilli,
V. Vaira,
C. Pellegrini,
M. Roncalli,
G. Coggi,
S. Bosari
|
7 |
2009 |
7
🐜
|
